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SUMMARY
BAFF, an activator of the noncanonical NFκB pathway, provides critical survival signals during B 
cell maturation and contributes to B cell proliferation. We found that the NFκB family member 
RelB is required ex vivo for B cell maturation, but cRel is required for proliferation. Combined 
molecular network modeling and experimentation revealed Nfkb2 p100 as a pathway switch; at 
moderate p100 synthesis rates in maturing B cells, BAFF fully utilizes p100 to generate the 
RelB:p52 dimer, whereas at high synthesis rates, p100 assembles into multimeric IκBsome 
complexes, which BAFF neutralizes in order to potentiate cRel activity and B cell expansion. 
Indeed, moderation of p100 expression or disruption of IκBsome assembly circumvented the 
BAFF requirement for full B cell expansion. Our studies emphasize the importance of p100 in 
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determining distinct NFκB network states during B cell biology, which causes BAFF to have 
context-dependent functional consequences.
Graphical abstract
INTRODUCTION
Mature follicular B cells are largely responsible for thymus (T)-dependent antigenic 
responses. Two receptors critical for follicular B cell maintenance and expansion are the B 
cell antigen receptor (BCR) and the B-cell-activating factor receptor (BAFF-R). BCR is 
critical for antigen-responsive expansion and maintenance of the mature B cell pool (Lam et 
al., 1997). BAFF-R (and BAFF) is critical for the survival of maturing transitional B cells 
(Harless et al., 2001; O’Connor et al., 2004; Schiemann et al., 2001), enhances follicular B 
cells, enhances antigen-responsive B cell expansion in vitro (Huang et al., 2004; Rickert et 
al., 2011; Schweighoffer et al., 2013), and strengthens T cell-dependent and independent 
humoral immune responses (Do et al., 2000; Litinskiy et al., 2002). Indeed, whereas 
initiation of germinal center formation was found to be independent of BAFF, the B cell 
responsiveness to antigens (via the BCR) is impaired in BAFF-signaling-deficient mice 
(Rahman et al., 2003; Vora et al., 2003).
BCR and BAFF-R are known to signal to NFκB via two distinct pathways: the NEMO-
dependent “canonical” pathway and the NEMO-independent “noncanonical” pathway, 
respectively. Activated BCR recruits the Carma1-Bcl10-Malt1-containing complex to the 
membrane, triggering NEMO ubiquitination and activation of the NEMO-containing IKK 
complex. This leads to nuclear translocation of preexisting RelA- and cRel-containing NFκB 
dimers from the latent IκB-inhibited cytoplasmic complexes (Hayden and Ghosh, 2008). 
BAFF-R stimulation sequesters TRAF3, resulting in the stabilization of NIK and activation 
of a NEMO-independent IKK1 kinase complex. This stimulates p100 processing to p52 and 
results in nuclear accumulation of RelB:p52 dimers (Claudio et al., 2002).
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Recent studies have begun to address the molecular basis for the functional interactions 
between BCR and BAFF-R. Tonic BCR signaling and associated canonical pathway activity 
are critical for the constitutive expression of the Nfkb2 gene generating p100 substrate for 
NIK/IKK1-dependent processing and production of RelB:p52 dimer in maturing B cells 
(Cancro, 2009; Stadanlick et al., 2008). Similarly, lymphotoxin-beta receptor-responsive 
noncanonical pathway activation was found to be dependent on constitutive canonical 
signaling (Basak et al., 2008). In the context of resting B cells, RelB is a presumed mediator 
of BAFF’s survival functions dependent on tonic BCR. Extending this model to proliferating 
B cells suggests that heightened BCR-responsive canonical activity might strengthen BAFF-
mediated activation of RelB. In other words, a costimulatory role of BAFF in the expansion 
of activated B cells might be achieved through RelB-mediated enhanced cell survival. 
However, there are indications that BAFF may in fact not only enhance cell survival but 
contribute to cell cycle entry of mature follicular B cells following antigenic stimulation 
(Allman et al., 2001; Do et al., 2000; Huang et al., 2004; Patke et al., 2006). It is unknown 
whether this function may also involve NFκB signaling or be entirely mediated by other 
signaling axes known to be activated by BAFF, such as phosphatidylinositol 3-kinase (PI3K) 
or mitogen-activated protein kinase/ERK (Jellusova et al., 2013; Mackay and Schneider, 
2009; Mackay et al., 2007; Rickert et al., 2011), which are also mediators of BCR signaling 
(Srinivasan et al., 2009) and potential crosstalk regulators (Schweighoffer et al., 2013).
Here, we addressed the role of the NFκB-signaling system in mediating BAFF’s functions in 
both maturing as well as proliferating B cells using quantitative cell biology, biochemistry, 
and mathematical modeling. In particular, we offer genetic evidence that RelB is indeed 
critical for BAFF-induced survival of maturing B lymphocytes in vitro but the costimulatory 
effect of BAFF in BCR-triggered population expansion is not based on enhanced B cell 
survival or elevated RelB activity. Instead, BAFF costimulation augments BCR-triggered 
cRel activation and the fraction of B cells entering the proliferative program. Quantitative 
analysis of the NFκB network reveals that cRel hyperactivation is achieved by BAFF 
neutralizing the inhibitory effect of BCR-induced p100, which was shown to assemble into a 
multimeric IκBsome (Savinova et al., 2009) with associated IκBδ activity (Basak et al., 
2007; Shih et al., 2009).
RESULTS
BAFF-R Enhances BCR-Triggered B Cell Expansion
Prior work has established that BCR and BAFF-R activate distinct NFκB-signaling 
pathways, the so-called canonical, NEMO-dependent and the noncanonical, NEMO-
independent pathways, respectively (Figure 1A). Whereas the primary transcriptional 
effector of the former is NFκB cRel, which enhances cell survival and may initiate the B-
cell-proliferative program, the latter is known to activate RelB. Both receptors also activate 
other signaling pathways such as PI3K and ERK that contribute to their physiological 
functions (Mackay et al., 2007; Otipoby et al., 2008; Ramakrishnan et al., 2004).
We asked whether BAFF costimulation would enhance BCR-triggered B cell expansion via 
enhanced cell survival or whether other signaling crosstalk mechanisms might be involved. 
Using the cell-tracking dye carboxyfluorescein succinimidyl ester (CFSE), we monitored 
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splenic B cell expansion following BCR crosslinking with anti-immunoglobulin M (IgM). 
Costimulation of BAFF-R increased this B cell expansion (Figures 1B and S1), confirming 
previous studies (Craxton et al., 2007; Huang et al., 2004; Schweighoffer et al., 2013; 
Stadanlick et al., 2008). To determine how BAFF affected B cell population dynamics, we 
employed the software tool FlowMax (Shokhirev and Hoffmann, 2013), which deconvolutes 
dye dilution data to determine the fraction of cells entering the proliferative program (pF) 
and the associated cell division (Tdiv) as well as cell survival (Tdie) times. This automated 
interpretation of CFSE data suggest that BAFF not only increased the lifetime of B cells 
(from 40 to 61 hr) but also increased the fraction of responding cells entering the 
proliferative program from 5% to 15% (Figure 1C). However, the time required for first cell 
division remained relatively constant at 43–48 hr. Indeed, 7-amino-actinomycin D (7AAD) 
staining revealed fewer dying cells at 24 hr (Figure 1D), but at a longer time course, the 
number of live cells actually increased with BAFF (Figure 1E), consistent with previous 
reports that BAFF is able to contribute to cell cycle entry as well (Do et al., 2000; Huang et 
al., 2004; Patke et al., 2006).
The transcriptomic response to costimulation, as revealed by RNA sequencing (RNA-seq) 
analysis, included a substantial number of genes (171; Figures 2A and 2B), many of which 
were dependent on BAFF costimulus (87 were reduced >20.5-fold in single anti-IgM 
stimulation conditions). Gene ontology analysis revealed terms like “metabolic process” and 
“biological regulation” scoring highly, whereas regulation of cell death or cell proliferation 
did not (Figure 2C). Remarkably, motif analysis of the regulatory region (−1,000 to +300 of 
the transcription start site) of these hyperinduced genes revealed the κB motif as being 
substantially overrepresented. In particular, using previously characterized NFκB-binding 
motifs (Siggers et al., 2012), we found that the cRel:p50-binding motif is present in 56% of 
the proximal regulatory regions of these hyperexpressed genes, regardless of their gene 
ontology categorization. Of these 81 “late” hyperinduced genes, we identified some 
candidates involved in prosurvival and cell cycle processes (Figures 2B and 2D). 
Examination of these hyperexpressed regulators of survival and cell cycle by quantitative 
PCR revealed that their full expression depended on cRel (Figure 2E).
To determine which NFκB activity was hyperinduced, we examined NFκB DNA-binding 
activities biochemically using electrophoretic mobility shift assays coupled with antibody 
supershift to ablate all but the NFκB dimer of interest. Anti-IgM stimulation was found to 
induce a transient cRel activity within the first few hours, followed by a return to basal levels 
by 24 hr (Figure 2F). BAFF stimulation alone activated cRel similarly and also resulted in 
long-lasting RelB DNA-binding activity. Upon costimulating BCR and BAFF-R, we 
observed surprisingly little change in the induced RelB activity but found that cRel DNA-
binding activity was enhanced in amplitude at 12 hr as well as prolonged in duration up to 
40 hr. Quantitation of the data confirmed that costimulation provides for “superactivated” 
cRel, but not RelB (Figure 2F, right). Interestingly, RelA-containing dimers are rapidly 
induced upon solitary anti-IgM or BAFF treatment, but basal levels are restored within 
roughly 6 hr. And like RelB, these kinetics are nearly identical in costimulated conditions. 
We examined expression of these NFκB family members at both the mRNA and the protein 
level (Figures S3A and S3B) but found little to no increase in the costimulation state 
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compared to individual BCR or BAFF-R stimulation, in contrast to the results of the DNA-
binding activity analysis.
Differential Requirements for cRel and RelB in Resting and Proliferating B Cells
We then investigated the genetic requirement of cRel and RelB NFκB family members in 
mediating BAFF’s functions in B cells. Mature follicular B cells subsets are the strongest 
responders to anti-IgM-induced proliferative signals, and their development is unaffected by 
lack of either cRel or RelB, though RelB−/− mice lack marginal zone B cells (Weih et al., 
2001). We first examined in vitro survival of total B cell population cultured in BAFF to find 
significant impairment in the absence of RelB (Figure 3A) and also a reduction, though less 
severe, in the absence of cRel. Charting a longer time course confirmed the importance of 
RelB and, to a lesser extent, cRel in BAFF-R-induced survival of B cells in vitro (Figure 3A, 
right). We note, however, that in vivo Relb and also Ikk1 appear to be redundant with other 
pathways, as the respective knockouts do not show deficiencies in B cell numbers (Jellusova 
et al., 2013). Turning to BAFF’s role as a costimulus during BCR-triggered B cell 
expansion, fluorescence-activated cell sorting (FACS) analysis of the CFSE-labeled total B 
cell population revealed that enhanced B cell expansion in response to costimulation did not 
require RelB (Figure 3B) but was dependent on cRel (Figure 3C), mimicking B cell 
responses to solitary BCR stimulation (Cheng et al., 2003; Grumont et al., 1998, 1999).
To substantiate these conclusions, we utilized a newly developed mouse model for RelB 
dysfunction, in which RelB’s ability to bind DNA was inactivated by substitution of three 
amino acids identified based on protein structure data. These RelBdb/db mice phenocopy 
RelB−/− in all aspects examined thus far (data not shown). We isolated RelBdb/db follicular B 
cells to ~85% purity (Figure S2) and compared their proliferative responses with wild-type 
or Crel−/− CD23+ follicular B cells upon BAFFR+BCR costimulation. Analysis of CFSE-
stained follicular B cells revealed substantially enhanced B cell expansion in both wild-type 
and Relbdb/db, but not in Crel−/−, genotypes (Figure 3D). Total cell number measurements 
reflect this requirement, as Crel−/− B cells decline much more rapidly than wild-type 
controls and Relbdb/db shows no obvious deficiency in costimulation conditions (Figure 3D, 
right). Computational deconvolution of the CFSE data confirmed that cRel is required not 
only for allowing B cells to enter the proliferative program (pFs) but also for Tdie, whereas 
RelB deficiency had no discernible effect (Figure 3E).
In sum, these studies indicate a differential requirement for cRel and RelB for BAFF’s 
physiological function. When B cells are cultured in BAFF, its survival signals are mediated 
in part by RelB; however, when BAFF functions as a costimulus to BCR, we observed 
superactivation of cRel, which mediates the enhanced population expansion by increasing 
the proportion of cells entering the proliferative program.
BAFF Relieves p100/IκBδ Termination of cRel Activity
These observations seemed reminiscent of noncanonical pathway activation of NFκB RelA 
observed in LTβ-treated fibroblasts (Basak et al., 2007) and led us to hypothesize that p100 
not only functions as a precursor for p52 generation via processing but also for 
oligomerization to form the high-molecular-weight IκBsome complexes that contain IκBδ 
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activity (Figure 4A). When p100 expression is high due to BCR-stimulated RelA and cRel 
activity, the latter mechanism might lead to post-induction repression of cRel akin to IκBδ-
mediated repression of lipopolysaccharide-induced RelA activity in mouse embryonic 
fibroblasts (MEFs) (Shih et al., 2009). BAFF as a costimulus with IgM might thus neutralize 
the IκBδ-mediated negative feedback to prolong canonical NFκB responses.
To examine this hypothesis, we first showed that the three canonical IκBs, IκBα, IκBβ, and 
IκBε, showed characteristic degradation at early and induction at late time points in response 
to anti-IgM was unchanged when BAFF was applied as a costimulus (Figure S3C) as was 
the IKK activity profile (Figure S3D). In contrast, p100 was not subjected to IgM-mediated 
initial degradation but rather was induced from 12 hr on, and this late induction was almost 
completely absent in costimulation conditions (Figure 4B). Further, cRel 
immunoprecipitates revealed substantial p100 interaction following 24 hr of IgM 
stimulation, but this was largely absent in the costimulation condition (Figure 4C). This time 
point coincides with the presence of superactivated cRel observed by electrophoretic 
mobility shift assay (EMSA; Figure 2F). In contrast, IκBα and IκBε interaction with cRel 
was similar between IgM-stimulated and BAFF-costimulated cells, with similar transient 
reduction at the early 3 hr time point. In sum, these observations support the hypothesis that 
p100 forms an inhibitory IκBδ-containing complex, which limits cRel activity during BCR-
triggered B cell expansion and which may be neutralized by BAFF-costimulation to prolong 
cRel activation.
To test this hypothesis more quantitatively (and thus determine whether it provides a 
sufficient explanation) and develop a research tool that may complement wet lab 
experimentation, we constructed a mathematical model of the NFκB-signaling system in B 
cells, capable of responding to both canonical and noncanonical signals induced by BCR 
and BAFFR. Development of the mathematical model began with delineation of the model’s 
topology, based on previously established models of lesser scope. We distinguish between 
reactions that control IκB synthesis and degradation (Figure S4A) and those that control 
NFκB monomer synthesis, dimerization, and interactions of dimers with IκBs (Figure S4B). 
The former represents an extension of the previously published four-IκB model (Basak et 
al., 2007; Shih et al., 2009), and the latter is an extension of a model of RelA and RelB 
dimers in dendritic cells (Shih et al., 2012) to include cRel as well (see also Tables S1 and 
S2). Thus, we account for all p50- and p52-containing dimers and the associated 19 NFκB-
IκB complexes. The two topologies are connected not only via protein-protein interactions 
but also via NFκB-dependent synthesis control and the dual roles of the Nfkb2 gene product 
p100 as a precursor not only for the NFκB dimerization partner p52 but also for the IκBδ 
activity contained within the multimeric IκBsome. Data in Figures 1, 2, and 3 and 
quantitation of polypeptides (Figure S5; Table S3) provide an extensive training set to 
achieve a B-cell-specific parameterization.
To account for cell-to-cell heterogeneity of B cell responses, each condition was simulated 
with distributed kinase input profiles that may result from heterogeneous BCR-induced 
signaling (Shinohara et al., 2014; Figure S6); their average conforms to the experimentally 
measured profiles of IKK activity (Figure S3D). The similarly averaged simulations of IκB 
and NFκB dynamics show that cRel-containing dimers are transiently induced, peaking at 
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about 5 hr before returning to basal levels in response to BCR or BAFF-R stimulation alone 
(Figure 4D, third row), whereas RelB-containing dimers are induced late and in a sustained 
and BAFF-R-dependent manner (Figure 4D, fourth row); these simulation outputs match our 
biochemical analysis at late times (Figure 3A), though early RelB activity observed 
experimentally eludes the present version of the model. Finally, simulation of the 
costimulation scenario (Figure 4D, third column) reveals a RelB profile that is surprisingly 
unchanged from the BAFF-alone condition and a cRel profile that shows superactivation at 
both early (1–4 hr) and late times (20–40 hr). Whereas early superactivation coincides with 
elevated NEMO-IKK activity, late superactivation does not. Instead, late cRel 
superactivation coincides with a BAFF- and NIK-dependent reduction in p100/IκBδ 
abundance at late times, which neutralizes its IgM-driven hyperexpression. In sum, 
mathematical modeling demonstrates that kinetic considerations alone are sufficient to 
account for context-specific NFκB effectors of BAFF-R signaling without the need to invoke 
context-specific molecular mechanisms.
p100/IκBδ Limits cRel-Mediated B Cell Expansion
The mathematical model encapsulates the key hypothesis that BAFF functions to relieve 
IκBδ-mediated termination of cRel activity. Model simulations suggested that a 2-fold 
reduction in the Nfkb2 mRNA synthesis rate, akin to Nfkb2 heterozygosity, would result in 
reduced p100 protein in both basal and IgM-stimulated conditions in silico (Figure 5A), 
which was confirmed in cells (Figure 5B). Unlike Nfkb2−/− mice, we found that Nfkb2+/− 
mice showed normal follicular B cell populations (Figures S7A and S7B). Further, the 
model predicted that the amount of inhibited cRel-p100 complex following 24 hr of anti-
IgM stimulation would be reduced in Nfkb2+/− B cells compared to the wild-type controls 
(Figure 5C). Indeed, quantitative cRel coimmunoprecipitation revealed severely diminished 
p100 interaction in anti-IgM-treated Nfkb2+/− cells akin to those in BAFF-treated wild-type 
cells (Figure 5D). Next, model simulations predicted that Nfkb2 heterozygosity would 
enhance cRel activity at late times (24–48 hr; Figure 5E). Biochemical analysis confirmed 
this prediction, showing increased cRel DNA-binding activity at late times as compared to 
wild-type cells (Figure 5F). These studies establish the expression level of p100 as a 
remarkably sensitive parameter in terminating NFκB activity via the presumed multimeric 
IκBδ.
To examine the cell biological consequence of enhanced cRel activation in Nfkb2+/− B cells, 
we undertook CFSE dye dilution studies, which revealed that anti-IgM-stimulated Nfkb2+/− 
B cells showed enhanced B cell expansion over wild-type controls (Figure 5G). 
Computational deconvolution (Figure 5H) showed that this increased expansion was 
primarily due to increases in the fraction of cell entering the proliferative program (pF), 
moderately for generation zero (pF0) but more so for subsequent generations (pF2, pF3, 
pF4, etc.). Further, survival times (Tdie0) increased, mimicking costimulation conditions. 
Our biochemical analysis, combined with enhanced proliferative capacity, document that 
Nfkb2 heterozygous B cells possess a heightened BCR responsiveness in vitro. To test 
whether this phenotype holds true in vivo, we immunized Nfkb2+/− mice with 4-hydroxy-3-
nitrophenyl keyhole limpet hemocyanin (NP-KLH) to induce a T-dependent antigen 
response and then examined antibody levels in sera (Figure 5I). We found a significant 
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increase of NP-specific IgM, IgG3, and IgG1 levels in Nfkb2+/− mice compared with wild-
type 10 and 28 days postimmunization. We also note an increase in total Ig Nfkb2+/− mice. 
These data are noteworthy because Nfkb2-knockouts, which lack not only IκBδ (deficient in 
Nfkb2+/−) but also survival-associated RelB:p52 (present in Nfkb2+/−), show reduced mature 
B cells and diminished antibody responses (Caamaño et al., 1998, Franzoso et al., 1998). 
Together, our data support the notion that the IκBδ-containing IκBsome plays a key role in 
terminating antigen-triggered B-proliferative responses and humoral immunity by limiting 
the duration of cRel transcription factor activity.
Nfkb1/p105 Stabilizes IκBδ to Control B Cell Expansion
To further test the model that the IκBδ-containing IκBsome is critical for terminating cRel-
driven B-cell-proliferative responses, we sought ways to perturb IκBsome formation. 
Previous biochemical studies described an assembly pathway for high-molecular-weight 
IκBsome involving mutually stabilizing interactions between the Nfkb1 and Nfkb2 gene 
products p105 and p100 (Savinova et al., 2009). In addition, p50 and p52 have been 
described to compete for a limited pool of activation-domain-containing NFκB proteins, 
RelA, cRel, and RelB (Basak et al., 2008). Both mechanisms determine the balance between 
IκBsome formation by p100 and its processing to p50/p52. These interdependencies in p100 
and p105 (Figure 6A) allow for compensation for the absence of p50 by p52 (Hoffmann et 
al., 2003) but with concomitant loss of p100 and lymphotoxin-beta receptor responsiveness 
in Nfkb1−/− MEFs (Basak et al., 2008) and lymph node formation in Nfkb1−/− mice (Lo et 
al., 2006).
We examined whether Nfkb1 might be required for efficient IκBδ function during IgM-
triggered B cell expansion. Examination of B cell populations in Nfkb1-deficient mice was 
similar to wild-type controls (Figure S7C), and our quantitative gene-expression analysis 
confirmed that the steady-state and inducible levels of Nfkb2 mRNA are similar in Nfkb1−/− 
and wild-type B cells (Figure S7D). However, immunoblot analysis of Nfkb1−/− B cell 
extracts indicated lower levels of p100 protein and elevated levels of p52 (Figure 6B). This 
decrease in the available p100 pool was also evident in the cytoplasmic fraction (Figure 6C). 
Immunoblotting nuclear fractions, we detected elevated cRel levels in BCR-stimulated 
Nfkb1−/− B cells over wild-type counterparts (Figure 6D). These data suggest that Nfkb1 
deficiency destabilizes p100-containing IκBδ to neutralize its inhibition of cRel activity. 
Coimmunoprecipitation analysis confirmed that p100 was bound to a lesser extent to cRel in 
anti-IgM-treated Nfkb1−/− B cells than wild-type controls (Figure 6E).
Next, we examined BCR-triggered B cell expansion with CFSE dye dilution analysis. FACS 
analysis revealed enhanced proliferative responses in Nfkb1−/− B cells compared to wild-
type controls (Figure 6F). Computational deconvolution identified that the phenotype was 
primarily due to a greater fraction of cells entering the proliferative program with only minor 
changes in cell division or survival times (Figure 6G). Although Nfkb1/p50 is a known 
dimerization partner of cRel, our data suggest that Nfkb1’s primary role in antigen-
responsive B cell expansion is to limit the proliferative program by Nfkb1/p105-stabilizing 
IκBδ.
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DISCUSSION
The tumor necrosis factor (TNF) superfamily member BAFF has diverse roles during B 
lymphocyte development, homeostasis, and pathogen-responsive expansion. Using an 
iterative systems biology approach, we identified two distinct molecular mechanisms and 
transcriptional effectors that mediate them. Whereas BAFF’s survival function in maturing B 
cells is mediated by the noncanonical NFκB pathway effector RelB, its function as a 
costimulus in antigen-responsive B cell expansion is mediated by superactivation of cRel 
that enhances the fraction of cells entering the proliferative program. Our studies reveal 
Nfkb2 /p100 as the critical pathway switch, as it functions as the precursor not only for 
protein processing to p52 but also for IκBδ and IκBsome assembly. Our data support a 
model in which the multimeric IκBδ activity limits the cRel-driven-proliferative program, 
and BAFF activation of the noncanonical pathway neutralizes the IκBδ negative feedback 
loop.
Previous studies established that BAFF engages the noncanonical NFκB-signaling pathway, 
which activates NFκB activity via NEMO-independent kinases NIK and IKK1. A hallmark 
of noncanonical NFκB activity is RelB:p52 activation. Although NIK, cRel, and RelA have 
been shown to be required for normal B cell homeostasis, no genetic evidence pointed to the 
necessity of RelB. Here, we showed that BAFF-induced survival of resting splenocytes in 
vitro is indeed RelB dependent (Figure 3B).
However, when employing BAFF as a costimulus during antigen-receptor-triggered B cell 
expansion, we found that RelB was dispensable (Figure 3D), prompting us to search for 
other relevant effectors. One clue was provided by the unbiased, software-aided analysis of 
the CFSE dye dilution data of BCR and BAFF/BCR-costimulated B cells: enhanced 
expansion was largely due to an increased fraction of cells entering the cell division 
program, particularly at later generations. B cell proliferation is known to be mediated by 
cRel (Grumont et al., 1998), and we found dramatic superactivation of cRel in costimulation 
conditions but little enhancement in RelB activity. Further, our transcriptomic studies 
identified enrichment of cRel-binding regulatory motif (Figures 2A and 2C) and genetic 
cRel dependency (Figure 2E) in genes with enhanced expression during costimulation.
The TNF superfamily receptors, BAFF-R and transmembrane activator and CAML 
interactor (TNFRSF13B) (TACI), are expressed on all B cell subsets and mediate BAFF 
function (Shulga-Morskaya et al., 2004). Whereas TACI is known to activate the canonical 
NFκB pathway (Marsters et al., 2000), recent studies have also implicated BAFF-R (Enzler 
et al., 2006) and shown that BAFF stimulation of Taci−/− B cells also leads to IκBα 
degradation and canonical pathway activation (Shinners et al., 2007). Although early cRel 
activation (3–8 hr) may be attributed to such canonical activation by TACI and BAFF-R, late 
cRel activity (24–48 hr) only appears in costimulation conditions (Figure 3A).
How does BAFF-R allow for late superactivation of cRel in proliferating B cells? One 
mechanism might be the generation of a cRel:p52 dimer as a result of enhanced p100 
processing; we indeed saw increased amounts of p52 bound to cRel in 
coimmunoprecipitation experiments (data not shown), though this remained a minor 
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component of the DNA-protein complex found in EMSAs. The primary mechanism 
appeared to be the derepression of cRel activity via the previously described IκBδ activity, 
which results from oligomerized Nfkb2 p100 (Basak et al., 2007) within the high-molecular-
weight IκBsome (Savinova et al., 2009). Indeed, progressive maturation of the IκBsome to a 
high-molecular-weight complex with potent NFκB inhibitor function begins with RelA-
responsive expression of both p100 and p105 and requires their mutual interactions (Basak 
et al., 2007; Savinova et al., 2009; Shih et al., 2009).
By describing the signaling network in mathematical terms, we could show that known 
molecular mechanisms and kinetic rate constants (experimentally determined or inferred 
within a reasonable range) are sufficient to account for the observed molecular and genetic 
phenomena in both maturing and proliferating B cells. Further, using computational 
simulations, we developed hypotheses that distinguished the IκBsome model from the 
alternative RelB:p52 model. Testing these hypotheses experimentally, we showed (1) that 
reduced p100 expression levels (with Nfkb2 heterozygous B cells) result in elevated levels 
of nuclear cRel at late times and increased B cell proliferation (rather than decreased 
proliferation that would be expected if RelB:p52 was the relevant effector) and (2) that 
disruption of the IκBsome assembly pathway (due to p105 deficiency) would also relieve 
cRel inhibition, resulting in enhanced expansion and mimicking the costimulated state. Our 
results do not contradict previous work that tonic canonical NFκB signaling in resting B 
cells is required for noncanonical RelB:p52 activation (Shinners et al., 2007; Stadanlick et 
al., 2008). The quantitative description of the network clarifies that low-RelA/cRel activity is 
required to generate p100 as a substrate for processing to p52 (as well as RelB; Basak et al., 
2008) for RelB:p52 generation (Shinners et al., 2007; Stadanlick et al., 2008) but that 
elevated p100 production, as it occurs in proliferating conditions, results in an excess of 
p100 molecules that then assemble into the IκBsome, which BAFF in turn neutralizes.
Our work here on the IκBsome’s role in lymphocyte expansion may be a description of its 
physiological significance. Future studies may implicate it in other physiological functions. 
Indeed, phenotypes associated with C-terminal deletions of the Nfkb1 and Nfkb2 genes 
reported many years ago (Caamaño et al., 1998; Migliazza et al., 1994) may best be 
understood in terms of disrupted IκBsome assembly. Further, cancer-associated mutations in 
B cell lymphoma or multiple myeloma affecting the noncanonical signaling pathway likely 
function by disrupting the normal buffering functions of the IκBsome (Busino et al., 2012; 
Hailfinger et al., 2009; Lim et al., 2012).
EXPERIMENTAL PROCEDURES
B Cell Isolation, Proliferation, and Survival Analysis
Spleens were harvested from C57Bl6 wild-type or littermate Relb−/−, RelBdb/db, Crel−/−, 
Nfkb1−/−, and Nfkb2+/− mice. For B cell isolation, homogenized splenocytes were incubated 
with anti-CD43 microbeads for 15 min at room temperature, washed with FACS buffer, and 
separated on LS column (Miltenyi Biotec). Purity was confirmed to be ~92%–95%. 
Marginal Zone and Follicular B Cell Isolation Kit (Miltenyi Biotec) was used for separation 
of follicular B cells from whole splenocytes, with a purity of 83%–87% CD23+ follicular B 
cells (Figure S2). Complete media consisted of RPMI-1640, 10 mM HEPES, 0.055 mM β-
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mercaptoethanol, penicillin and streptomycin, and l-glutamine. B cells were stimulated with 
5 µg/ml of Fab anti-mouse IgM (Jackson Immunology Research) and/or 50 ng/ml 
recombinant mouse BAFF (R&D Systems). In vitro proliferation assay was performed using 
CFSE tracking dye as described (Hawkins et al., 2007). Data were collected on a C6 Accuri 
(BD Biosciences) or FACSCalibur and analyzed with FlowJo software and FlowMax 
(Shokhirev and Hoffmann, 2013). B cell survival was determined by 7ADD staining using 
FlowJo for data analysis.
Biochemical Assays
Immunoblotting analysis, EMSAs, and kinase assays were conducted with standard methods 
as described previously (Shih et al., 2012; Werner et al., 2005) and antibodies specific for 
RelA (Santa Cruz Biotechnology; sc372), RelB (sc226), cRel (sc71), IκBα (sc371), IκBε 
(sc7155), α-tubulin (sc226), p100, and p105 (Dr. Nancy Rice). For EMSAs focusing on 
cRel-DNA-binding activity, nuclear extracts are preincubated with RelA and cRel antibodies 
for 15 min on ice prior to addition of radiolabeled probe to ablate their respective DNA-
binding activities. Similarly, nuclear extracts were preincubated with RelA and cRel 
antibodies or RelB and cRel antibodies when RelB- or RelA-DNA-binding activity was the 
focus, respectively. RNAeasy Mini Kit (QIAGEN) was used to purify RNA. cDNA synthesis 
performed with iScript cDNA Synthesis Kit (Bio-Rad). Quantitative RT-PCR was performed 
with SYBR Green PCR Master Mix reagent using the Δ(ΔCt) method with β-actin as 
normalization control, relative to unstimulated signals in wild-type B cells to derive fold 
induction.
RNA-Seq Analysis
Total RNA was isolated from 50 ng/ml BAFF-stimulated wild-type B cells following 8 and 
30 hr of culture. mRNA was extracted from 2 µg total RNA using oligo (dT) magnetic beads 
and fragmented at high temperature using divalent cations. cDNA libraries were generated 
using the IlluminaTruSeq kits, and quantitation was performed using the Roche Light Cycler 
480. Sequencing was performed on Illumina’s HiSeq 2000, according to manufacturer’s 
recommendations, and prepared for RNA sequencing analysis by BIOGEM core facility at 
University of California, San Diego. Reads were aligned to the mouse mm10 genome and 
RefSeq genes (Kent et al., 2002; Waterston et al., 2002) with Tophat (Trapnell et al., 2009). 
Cufflinks CummRbund (Trapnell et al., 2012) was used to ascertain differential expression 
of genes. Gene differential fragments per kilobase of transcript per million mapped reads 
were obtained from the cuffdiff program in Tuxedo RNA-seq analysis suite.
Immunization
The primary immune response to T-dependent Ag was assessed after intraperitoneal 
immunization with 50 µg of NP-KLH precipitated in alum. Sera were collected 10 and 28 
days after challenge and tested by ELISA. Briefly, plates were coated with 10 µg/ml NP-
BSA (Biosearch Technologies) and sera were assessed at 1/100,000 dilution. Bound 
antibodies (Abs) were detected with HRP-conjugated Abs to total mouse Ig or specific 
mouse isotypes (eBioscience and Santa Cruz Biotechnology).
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Computational Modeling
The ordinary differential equations model of multi-NFκB control was adapted from previous 
iteration of the B cell IκB-NFκB-signaling model (Alves et al., 2014) and a previous version 
of dendritic cell IκB-NFκB-signaling model (Shih et al., 2012) to account for activities of 
RelA:p50, RelA:p52, RelB:p50, RelB:p52, cRel:p50, and cRel:p52 dimers (Table S1). 
Parameterization of the reaction of the model (Table S2) included quantitative measurements 
of B cell protein abundances (Table S3). The model describes the single-cell response within 
a population of B cells; variability of NFκB response among cells is assumed to be due to 
variability (log normally distributed) in the activation of NEMO-IKK2. Based on FACS 
experiments, the fraction of 10% BCR-responsive cells was derived. In response BAFF 
stimulation, we assume all cells accumulate NIK and have low log-normally distributed 
NEMO-IKK2 activity. Hence, costimulation results in 20% cells with NEMO-IKK2 activity, 
and 80% have BAFF-induced NEMO-IKK2 activity. To allow comparison with experimental 
measurements of the bulk population, we graphed the average of 1,000 simulations of single 
B cells. The ordinary differential equations were solved numerically using MATLAB 
version R2013a (The MathWorks) with subroutine ode15s. Following system equilibration, 
anti-IgM and BAFF stimulation was simulated with numerical NEMO-IKK input curves 
(adapted from Werner et al., 2005) and by decreasing the NIK degradation rate constant by 
30-fold at 5 hr. MATLAB model codes are available upon request.
Animal Use
The animal protocols for this study were approved by the University of California, San 
Diego Animal Care and Use Committee. Generation of the RelBdb/db mouse strain 
containing mutations of residues required for DNA-binding R117A/Y120A/E123A will be 
described elsewhere.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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In Brief
Almaden et al. show that BAFF, an activator of the noncanonical NFκB pathway, 
provides critical B cell survival signals via RelB or contributes to B cell proliferation via 
cRel. An iterative systems biology approach revealed Nfkb2 p100 as a pathway switch 
that directs noncanonical NFkB signaling to either RelB:p52 activation or potentiation of 
cRel:p50.
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Highlights
• BAFF enhances in vitro survival of maturing B cells and aids B cell proliferation
• BAFF’s activation of RelB is required for enhanced cell survival, but not 
division
• In proliferating B cells, BAFF neutralizes p100-mediated termination of cRel
• Disrupting IκBδ expression/assembly mimics BAFF’s costimulation of B cell 
expansion
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Figure 1. BAFF Enhances BCR-Controlled B Cell Expansion
(A) Schematic of the distinct canonical and noncanonical NFκB pathways identified in B 
cells. Antigenic stimulation leads to release of cRel-containing dimers into the nucleus, 
resulting in activation of cell division programs (Grumont et al., 1998, 1999). BAFF 
activates noncanonical RelB dimers and B cell survival. Thus, this model suggests that 
BAFF costimulation results in enhanced expansion by augmenting survival of B cells.
Almaden et al. Page 18
Cell Rep. Author manuscript; available in PMC 2016 June 02.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
(B) In vitro proliferation of CFSE-labeled wild type B cells and stimulated for 3 days with 
anti-IgM alone (black) or anti-IgM + BAFF ligand (red) and analyzed by FACS. Live cell 
numbers gated by exclusion of 7AADHi population.
(C) The CFSE proliferation profiles of wild-type B cells stimulated with either anti-IgM or 
anti-IgM plus BAFF analyzed with FlowMax software tool to calculate the fraction of B 
cells responding to stimulation (pF), the average time to division of undivided (Tdiv0), and 
average time to death of undivided (Tdie0) cells.
(D) Representative histograms of cell survival analyzed by 7AAD staining following 24 hr 
of stimulation by anti-IgM alone (black) or anti-IgM + BAFF ligand (red).
(E) Time course averages of B cells viability stimulated with anti-IgM alone or anti-IgM + 
BAFF ligand. Live cells were identified by gating out 7AADHi population. FACS plots in 
(B) and (D) are representative of at least three experiments. Bar graphs in (C) summarize 
best-fit cellular parameters with the lognormal SD. Error bars in (E) SD; n = 3. *p < 0.05, 
**p < 0.01 by Student’s t test.
See also Figure S1.
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Figure 2. In the Context of BCR-Stimulated B Cells, BAFF-Induced Hyperexpression Shows a 
cRel Signature
(A) Venn diagram of gene sets identified by RNA-seq analysis (NCBI GEO accession 
number GSE54588) that are induced >2-fold over unstimulated wild-type B cells (t = 0 hr) 
following 30 hr of stimulation with anti-IgM alone (black), BAFF alone (blue), or anti-IgM 
and BAFF (orange).
(B) Heatmap of “hyper” expressed genes, defined as induced >log2(0.5) by anti-IgM at 30 
hr over unstimulated wild-type B cells (t = 0 hr) and possess an additional >log2(0.5) greater 
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expression in the anti-IgM and BAFF costimulation condition at the same time point. Of 
these genes, we identified a few genes involved in survival and cell cycle.
(C) Graphic representation of prosurvival and cell cycle genes in RNA-seq analysis in (B). 
The cRel:p50-binding motif is found overrepresented within the regulatory regions of 
hyperexpressed genes, regardless of the biological process they are categorized into.
(D) Quantitative PCR of wild-type B cells stimulated with either anti-IgM alone or in 
costimulation conditions. Relative expression normalized to the basal level is shown.
(E) Quantitative PCR of wild-type and cRel-deficient B cells costimulated with anti-IgM 
and BAFF for 24 hr. **p < 0.01 denotes significantly higher in wild-type condition than 
Crel−/− counterpart by Student’s t test.
(F) Time course of NFκB DNA-binding activities in anti-IgM alone, BAFF alone, and anti-
IgM plus BAFF costimulated B cells. Nuclear extracts from wild-type B cells activated by 
indicated stimuli were collected and subjected to RelA, cRel, and RelB EMSA (for cRel 
EMSA, RelA and RelB antibodies are incubated together with nuclear extracts in order to 
shift away these NFκB-containing dimers, leaving cRel species untouched; see 
Experimental Procedures). Signals quantified and graphed relative to their respective resting 
cells (left). EMSA is representative of five experiments. AU, arbitrary units.
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Figure 3. Costimulation of BCR and BAFF-R Result in Activation of cRel and RelB Dimers, but 
Enhanced Expansion Phenotype Is Dependent Solely on cRel
(A) Representative FACS plot of B cells derived from cRel (orange) and RelB (blue)-
deficient mice cultured with BAFF ligand for 3 days. Percentage of surviving B cells 
(7AAD−) was assessed by FACS and graphed on left; wild-type (black), Relb−/− (blue) and 
Crel−/− (orange).
(B and C) Total splenic wild-type, Relb−/−, and Crel−/− B cells are stained with CFSE and 
then stimulated with anti-IgM plus BAFF. Cell proliferation is examined at the indicated 
time points by FACS.
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(D) Time course for CFSE-labeled magnetically isolated follicular B cells (CD23+) from 
wild-type, Relbdb/db, and Crel−/− B cells stimulated with anti-IgM + BAFF ligand. Live cells 
numbers were identified by gating out 7AADHi population and graphed on left.
(E) FlowMax analysis of CFSE proliferation profiles for CD23+ wild-type, Relbdb/db, and 
Crel−/− B cells in (D). Bar graphs of pF0, Tdiv0, and Tdie0 with the lognormal SD provided.
FACS plots in (A)–(D) are representative of at least two independent experiments. Error bars 
represent SD; n = 3. *p < 0.05; **p < 0.01 by Student’s t test.
See also Figure S2.
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Figure 4. BAFF Releases IκBδ Inhibition of cRel in BCR-Stimulated B Cells
(A) Proposed mechanism of IκBδ inhibition of cRel in BCR-stimulated B cells. In resting B 
cells, BAFF-R stimulation activates the NIK/IKK1 kinase complex that results in p100 
processing, which allows for RelB:p52 nuclear translocation (Figure 3A). In activated B 
cells, continuous BCR stimulation activates cRel dimers, resulting in the expression of p100, 
which functions as a substrate for oligomerization to form the inhibitor IκBδ, which binds 
cRel, forming a negative feedback loop. During BAFF costimulation, the p100 buildup is 
prevented, allowing for persistent “superactivated” cRel.
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(B) Cytoplasmic protein levels of p100 in stimulated wild-type B cells were measured by 
immunoblot.
(C) Immunoblots of cRel coimmunoprecipitates prepared from wild-type B cells stimulated 
with anti-IgM, BAFF ligand, or anti-IgM and BAFF. Samples were normalized to cRel 
protein levels to allow for comparison of distinct conditions (left). Whole-cell lysates (input) 
are also presented. IP, immunoprecipitation.
(D) Computational simulations are shown for the NEMO/IKK2-inducing stimulus anti-IgM 
(left column), for the NIK/IKK1-inducing stimulus BAFF (middle column), and a 
combination of both (right column), namely NEMO/IKK2 and NIK/IKK1 activity profiles 
(top, black), NFκB family members cRel and RelB nuclear fold activities (middle, red), and 
total cellular protein levels of IκBα, IκBε, and ανδ p100 (IκBδ substrate; bottom, blue).
Gel images in (B) and (C) are representative of at least four experiments.
See also Figures S3–S6 and Tables S1–S3.
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Figure 5. IκBδ Limits the Proliferative Capacity of BCR-Stimulated B Cells
(A) Model simulation of fold p100 protein levels (log2) in wild-type (black) and Nfkb2 
heterozygous (green) B cells stimulated with anti-IgM alone.
(B) Immunoblot of p100 protein expression in wild-type and Nfkb2+/− B cells stimulated 
with anti-IgM alone. Blots were quantified and plotted (log2, right).
(C) Computational prediction of p100:cRel complex following 24 hr of anti-IgM stimulation 
in wild-type (black) and Nfkb2+/− (green) B cells.
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(D) Representative immunoblot blot for coimmunoprecipitation of p100:cRel complex from 
wild-type and Nfkb2+/− B cells following 24 hr of stimulation with either anti-IgM alone or 
anti-IgM plus BAFF ligand. Samples normalized to cRel protein levels (bottom). 
Immunoblots were quantified and graphed (right).
(E) Model simulation of nuclear cRel protein levels in wild-type and Nfkb2 heterozygous B 
cells stimulated with anti-IgM alone (log2).
(F) cRel DNA-binding activities in wild-type and Nfkb2 heterozygous B cells induced by 
anti-IgM alone were monitored by EMSA. EMSA was quantified and graphed (log2, right).
(G) Time course of cell proliferation for CD23+ wild-type (black) and Nfkb2+/− (green) B 
cells labeled with CFSE and 7AAD.
(H) FlowMax analysis of CFSE proliferation assay in (G).
(I) T-dependent Ag responses in Nfkb2+/− mice immunized with NP-KLH, and serum levels 
of anti-NP total Ig and specific Ig isotypes at 10 and 28 days postimmunization measured by 
ELISA (n = 5). Indicated p values are calculated by two-way ANOVA.
Unless stated, all experiments in Figure 5 used total splenic B cells. Immunoblots and FACS 
plot for (B), (D), (F), and (G) are representative of at least three experiments. Error bars in 
(D) SD; n = 3. Bar graphs in (H) summarize best-fit cellular parameters with the lognormal 
SD; *p < 0.05; **p < 0.01.
See also Figure S7.
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Figure 6. Nfkb1/p105 Limits the Proliferative Capacity of B Cells by Stabilizing p100/IκBδ
(A) Proposed schematic of Nfkb1 and Nfkb2 protein fates in wild-type and Nfkb1−/− B cells. 
In normal wild-type B cells, p105 and p100 mainly function in the NFκB-signaling system 
as precursors of p50 and p52. p105 is processed into p50 and dimerizes predominantly with 
cRel and RelA and, to a lesser extent, RelB. p100 processing yields p52, which in turn 
dimerizes with RelB primarily. A second function of p100 is to form the inhibitory molecule 
IκBδ (left). In Nfkb1−/− B cells, p105/p50 absence leaves cRel and RelA molecules without 
their primary binding partner. This in turn shifts the available pool of p100 to be processed 
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into p52 in order to overcome the loss of p50; as a result, less p100 is accessible to form 
IκBδ (right).
(B) Immunoblots of p52 whole-cell expression in wild-type and Nfkb1−/− B cells stimulated 
with anti-IgM. WCE, whole-cell extract.
(C) Immunoblots of cytoplasmic p100 expression in wild-type and Nfkb1−/− B cells 
stimulated with anti-IgM. CE, cytoplasmic extract.
(D) Immunoblot of nuclear cRel for wild-type and Nfkb1−/− B cells stimulated with anti-
IgM. Nuclear marker USF2 is used as a loading control. NE, nuclear extract.
(E) Immunoblots of immunoprecipitates to monitor p100/IκBδ (and p52) associated with 
cRel during BCR stimulation time course. cRel was immunoprecipitated from B cell whole-
cell extracts and prepared at indicated time points. Whole-cell lysates (input) are also shown; 
α-tubulin serves as loading control.
(F) FACS analysis for in vitro proliferation of wild type (black) and Nfkb1−/− (purple) B 
cells labeled with CFSE and stimulated for 3 days with anti-IgM alone. Live-cell numbers 
gated by exclusion of 7AADHi population.
(G) FlowMax analysis of CFSE proliferation profiles for wild-type (black) versus Nfkb1−/− 
(purple) B cells in (F).
Immunoblots and FACS plots for (B)–(F) are representative of at least three experiments. 
Bar graphs in (G) summarize best-fit cellular parameters with the lognormal SD.
See also Figure S7.
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